CLINICAL TRIALS PROFILE FOR AMZEEQ
✉ Email this page to a colleague
All Clinical Trials for AMZEEQ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04940767 ↗ | A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris | Recruiting | Vyne Therapeutics Inc. | Phase 4 | 2021-06-28 | Acne vulgaris is a common disease of both males and females, usually manifesting initially during adolescence. The use of retinoic acid analogues such as adapalene, tazarotene and isotretinoin are also commonly prescribed to treat inflammation; dysregulated sebum production and comedonal acne. This study seeks to evaluate the efficacy and safety of concomitant use of both AMZEEQ® and oral isotretinoin compared to oral isotretinoin only use and to explore sequence dosing of both products as part of a long-term management protocol for acne vulgaris. |
| NCT04940767 ↗ | A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris | Recruiting | Edward Lain, MD | Phase 4 | 2021-06-28 | Acne vulgaris is a common disease of both males and females, usually manifesting initially during adolescence. The use of retinoic acid analogues such as adapalene, tazarotene and isotretinoin are also commonly prescribed to treat inflammation; dysregulated sebum production and comedonal acne. This study seeks to evaluate the efficacy and safety of concomitant use of both AMZEEQ® and oral isotretinoin compared to oral isotretinoin only use and to explore sequence dosing of both products as part of a long-term management protocol for acne vulgaris. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMZEEQ
Condition Name
Clinical Trial Locations for AMZEEQ
Trials by Country
Clinical Trial Progress for AMZEEQ
Clinical Trial Phase
Clinical Trial Sponsors for AMZEEQ
Sponsor Name
